Submitted by Anonymous (not verified) on 8 July 2026 - 9:24
Orphan designation: igermetostat maleate Treatment of peripheral T-cell lymphoma, 20/05/2026 Positive
Source:
Orphan designation: igermetostat maleate Treatment of peripheral T-cell lymphoma, 20/05/2026 Positive